苯巴那酯（Ontozry）在国内上市了吗？有什么不良反应？

Epilepsy, commonly known as "epilepsy" or "epilepsy", is a chronic disease in which brain nerves suddenly discharge abnormally, causing temporary brain dysfunction. It can reduce repetitive neuronal discharges by inhibiting voltage-gated sodium currents and can be used to treat epilepsy. Today we will learn more about whether Ontozry is on the market in China? What are the adverse reactions?

Phenobarnate, also known as Xcopri, discovered and developed by South Korea's SK Biopharmaceuticals and its U.S. subsidiary SK Life Sciences, is a prescription drug used to treat partial-onset epilepsy in adults. The drug was launched in the United States in November 2019, but it is not currently available in China. Patients cannot buy this drug in domestic hospital pharmacies. Patients in need can contact the medical companion service staff to learn about the specific drug price and drug purchase process.

Phenobarnate is a sodium channel Blockers can reduce the frequency of epileptic seizures and have significant therapeutic effects. However, the drug also has side effects. Suicidal behavior, increased eosinophilia and systemic symptoms (DRESS)/multiple organ hypersensitivity reactions, shortened QT interval on electrocardiogram, adverse reactions of the nervous system (asthenia, insomnia, drowsiness, fatigue, weakness, sedation), etc. are all side effects of phebanate. Patients should pay attention to their own reactions during medication, read the instructions carefully before taking the medication, and follow the doctor's instructions. Do not change the dosage and usage of the drug at will to avoid the patient's intolerance reaction and affect the original condition.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: